12:00 AM
 | 
Sep 29, 2008
 |  BioCentury  |  Product Development

Beta blocker profile

Beta blocker profile

Bucindolol (BEST) Coreg (COPERNICUS)
Endpoints All comers (n=2,708) HR [95% CI] Homozygous (n=493)...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >